The clinical praxis of bacteriocins as natural anti-microbial therapeutics.


Journal

Archives of microbiology
ISSN: 1432-072X
Titre abrégé: Arch Microbiol
Pays: Germany
ID NLM: 0410427

Informations de publication

Date de publication:
30 Oct 2024
Historique:
received: 05 08 2024
accepted: 29 09 2024
revised: 25 09 2024
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

In recent decades, the excessive use of antibiotics has resulted in a rise in antimicrobial drug resistance (ADR). Annually, a significant number of human lives are lost due to resistant infectious diseases, leading to around 700,000 deaths, and it is estimated that by 2050, there could be up to 10 million casualties. Apart from their possible application as preservatives in the food sector, bacteriocins are gaining acknowledgment as potential clinical treatments. Not only this, these antimicrobial peptides have revealed in modulating the host immune system producing anti-inflammatory and anti-modulatory responses. At the same time, due to the ever-increasing global threat of antibiotic resistance, bacteriocins have gained attraction among researchers due to their potential clinical applications. Bacteriocins as antimicrobial peptides, represent one of the most important natural defense mechanisms among bacterial species, particularly lactic acid bacteria (LAB), that can fight against infection-causing pathogens. In this review, we are highlighting the potential of bacteriocins as novel therapeutics for inhibiting a wide range of clinically relevant and multi-drug-resistant pathogens (MDR). We also highlight the effectiveness and potential applications of current bacteriocin treatments in combating antimicrobial resistance (AMR), thereby promoting human health.

Identifiants

pubmed: 39476181
doi: 10.1007/s00203-024-04152-8
pii: 10.1007/s00203-024-04152-8
doi:

Substances chimiques

Bacteriocins 0
Anti-Bacterial Agents 0
Antimicrobial Peptides 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

451

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Abdul Hakim BN et al (2023) A comprehensive review of bioactive compounds from lactic acid bacteria: potential functions as functional food in dietetics and the food industry. Foods 12(15):2850
pubmed: 37569118 pmcid: 10417365 doi: 10.3390/foods12152850
Aljeldah MM (2022) Antimicrobial resistance and its spread is a global threat. Antibiotics 11(8):1082
pubmed: 36009948 pmcid: 9405321 doi: 10.3390/antibiotics11081082
Al-Omari AW, Matter IR, Almola AH (2022) An overview of bacteriocin. Samarra J Pure Appl Sci 4(2):58–72
Almeida-Santos AC et al (2021) Enterococcus spp. as a producer and target of bacteriocins: a double-edged sword in the antimicrobial resistance crisis context. Antibiotics 10(10):1215
pubmed: 34680796 pmcid: 8532689 doi: 10.3390/antibiotics10101215
Amado CM et al (2020) Bacteriocin enterocin CRL35 is a modular peptide that induces non-bilayer states in bacterial model membranes. Biochim Biophys Acta (BBA) Biomembr 1862(2):183135
doi: 10.1016/j.bbamem.2019.183135
Amenu D et al (2024) Antagonistic effects of lactic acid bacteria isolated from ethiopian traditional fermented foods and beverages against foodborne pathogens. Probiot Antimicrob Proteins 16(1):1–14
Andre C et al (2019) Changes in the composition and architecture of staphylococcal biofilm by nisin. Braz J Microbiol 50:1083–1090
pubmed: 31456169 pmcid: 6863270 doi: 10.1007/s42770-019-00135-w
Arnold BJ et al (2022) Horizontal gene transfer and adaptive evolution in bacteria. Nat Rev Microbiol 20(4):206–218
pubmed: 34773098 doi: 10.1038/s41579-021-00650-4
Azevedo I et al (2024) Lactic acid bacteria isolated from traditional and innovative alheiras as potential biocontrol agents. Food Microbiol 119:104450
pubmed: 38225051 doi: 10.1016/j.fm.2023.104450
Barathe P et al (2024) Antibiotic pollution and associated antimicrobial resistance in the environment. J Hazard Mater Lett 5:100105
doi: 10.1016/j.hazl.2024.100105
Barbosa AAT et al (2021) Nisin resistance in gram-positive bacteria and approaches to circumvent resistance for successful therapeutic use. Crit Rev Microbiol 47(3):376–385
pubmed: 33689548 doi: 10.1080/1040841X.2021.1893264
Bastos MDCDF et al (2015) Resistance to bacteriocins produced by gram-positive bacteria. Microbiology 161(Pt_4):683–700
pubmed: 25406453 doi: 10.1099/mic.0.082289-0
Bendjeddou K et al (2012) Characterization and purification of a bacteriocin from Lactobacillus paracasei subsp. paracasei BMK2005, an intestinal isolate active against multidrug-resistant pathogens. World J Microbiol Biotechnol 28:1543–1552
pubmed: 22805936 doi: 10.1007/s11274-011-0958-1
Bennett S et al (2022) Efficacy of bacteriocin-based formula for reducing staphylococci, streptococci, and total bacterial counts on teat skin of dairy cows. J Dairy Sci 105(5):4498–4507
pubmed: 35346465 doi: 10.3168/jds.2021-21381
Bharadwaj A et al (2022) Multidrug-resistant bacteria: their mechanism of action and prophylaxis. BioMed Res Int 2022(1):5419874
pubmed: 36105930 pmcid: 9467707
Bonhi K, Imran S (2019) Role of bacteriocin in tackling the global problem of multi-drug resistance: an updated review. Biosci Biotechnol Res Commun 12:601–608
doi: 10.21786/bbrc/12.3/8
Brainard J et al (2024) Emergency infection prevention and control training in fragile, conflict-affected or vulnerable settings: a scoping review. BMC Health Serv Res 24(1):937
pubmed: 39152446 pmcid: 11328436 doi: 10.1186/s12913-024-11408-y
Brüssow H (2024) The antibiotic resistance crisis and the development of new antibiotics. Microb Biotechnol 17(7):e14510
pubmed: 38970161 pmcid: 11226406 doi: 10.1111/1751-7915.14510
Bu Y et al (2022) Screening and probiotic potential evaluation of bacteriocin-producing Lactiplantibacillus plantarum in vitro. Foods 11(11):1575
pubmed: 35681325 pmcid: 9180163 doi: 10.3390/foods11111575
Bu Y et al (2023) Bacteriocin-producing Lactiplantibacillus plantarum YRL45 enhances intestinal immunity and regulates gut microbiota in mice. Nutrients 15(15):3437
pubmed: 37571374 pmcid: 10421436 doi: 10.3390/nu15153437
Butkhot N et al (2019) Characterisation and biosafety evaluation of a novel bacteriocin produced by Bacillus velezensis BUU004. Int Food Res J 26(5):1617–1625
Cai X et al (2024) Atomic structures of a bacteriocin targeting gram-positive bacteria
Carvalho FM et al (2020) The use of probiotics to fight biofilms in medical devices: a systematic review and meta-analysis. Microorganisms 9(1):27
pubmed: 33374844 pmcid: 7824608 doi: 10.3390/microorganisms9010027
Chakrobarty S et al (2023) Bioactive plantaricins as potent anti-cancer drug candidates: double docking, molecular dynamics simulation and in vitro cytotoxicity analysis. J Biomol Struct Dyn 41(23):13605–13615
pubmed: 36775653 doi: 10.1080/07391102.2023.2177732
Chandra P et al (2021) Antimicrobial resistance and the post antibiotic era: better late than never effort. Expert Opin Drug Saf 20(11):1375–1390
pubmed: 33999733 doi: 10.1080/14740338.2021.1928633
Chattopadhyay A et al (2023) Mechanism of action of the lantibiotics on the multidrug-resistant organisms. Lantibiotics as alternative therapeutics. Elsevier, Amsterdam, pp 85–117
doi: 10.1016/B978-0-323-99141-4.00010-2
Chen Y et al (2021) Current advancements in sactipeptide natural products. Front Chem 9:595991
pubmed: 34095082 pmcid: 8172795 doi: 10.3389/fchem.2021.595991
Cheng G et al (2019) Selection and dissemination of antimicrobial resistance in agri-food production. Antimicrob Resist Infect Control 8:1–13
doi: 10.1186/s13756-019-0623-2
Cheruvari A, Kammara R (2024) Bacteriocins future perspectives: substitutes to antibiotics. Food Control 168:110834
doi: 10.1016/j.foodcont.2024.110834
Chinemerem Nwobodo D et al (2022) Antibiotic resistance: the challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal 36(9):e24655
pubmed: 35949048 pmcid: 9459344 doi: 10.1002/jcla.24655
Chiumento S et al (2019) Ruminococcin C, a promising antibiotic produced by a human gut symbiont. Sci Adv 5(9):eaaw9969
pubmed: 31579822 pmcid: 6760926 doi: 10.1126/sciadv.aaw9969
Choi G-H et al (2023) Diversity of the bacteriocins, their classification and potential applications in combat of antibiotic resistant and clinically relevant pathogens. Crit Rev Microbiol 49(5):578–597
pubmed: 35731254 doi: 10.1080/1040841X.2022.2090227
Daba GM et al (2020) Bacteriocins of lactic acid bacteria as biotechnological tools in food and pharmaceuticals: current applications and future prospects. Biocatal Agric Biotechnol 28:101750
doi: 10.1016/j.bcab.2020.101750
de Almeida Vaucher R et al (2011) Evaluation of the immunogenicity and in vivo toxicity of the antimicrobial peptide P34. Int J Pharm 421(1):94–98
doi: 10.1016/j.ijpharm.2011.09.020
Dicks LMT et al (2018) A review: the fate of bacteriocins in the human gastro-intestinal tract: do they cross the gut–blood barrier? Front Microbiol 9:2297
pubmed: 30323796 pmcid: 6173059 doi: 10.3389/fmicb.2018.02297
Du J et al (2023) The research status, potential hazards and toxicological mechanisms of fluoroquinolone antibiotics in the environment. Antibiotics 12(6):1058
pubmed: 37370377 pmcid: 10295583 doi: 10.3390/antibiotics12061058
Duval V, Lister IM (2013) MarA, SoxS and Rob of Escherichia coli—global regulators of multidrug resistance, virulence and stress response. Int J Biotechnol Wellness Ind 2(3):101
pubmed: 24860636 pmcid: 4031692
Ellis J-C et al (2019) Nisin Z and lacticin 3147 improve efficacy of antibiotics against clinically significant bacteria. Future Microbiol 14(18):1573–1587
pubmed: 32019322 doi: 10.2217/fmb-2019-0153
Elsherif WM et al (2024) Natural approach of using nisin and its nanoform as food bio-preservatives against methicillin resistant Staphylococcus aureus and E. coli O157: H7 in yoghurt. BMC Vet Res 20(1):192
pubmed: 38734600 pmcid: 11088153 doi: 10.1186/s12917-024-03985-1
Esparza K (2019) Thiostrepton in phospholipid micelles: development of scalable production method and in vivo evaluation. University of Illinois at Chicago, Chicago
Espeche MC et al (2014) Physicochemical factors differentially affect the biomass and bacteriocin production by bovine Enterococcus mundtii CRL1656. J Dairy Sci 97(2):789–797
pubmed: 24359825 doi: 10.3168/jds.2013-7070
Feng Z et al (2020) Cloning and functional characterization of putative Escherichia coli ABC multidrug efflux transporter YddA. J Microbiol Biotechnol 30(7):982
pubmed: 32347079 pmcid: 9728188 doi: 10.4014/jmb.2003.03003
Ferrer-Bustins N et al (2024) The antilisterial effect of Latilactobacillus sakei CTC494 in relation to dry fermented sausage ingredients and temperature in meat simulation media. Fermentation 10(6):326
doi: 10.3390/fermentation10060326
Field D et al (2021) Bio-engineered nisin with increased anti-Staphylococcus and selectively reduced anti-Lactococcus activity for treatment of bovine mastitis. Int J Mol Sci 22(7):3480
pubmed: 33801752 pmcid: 8036683 doi: 10.3390/ijms22073480
Galván AE et al (2019) Microcin J25 inhibits ubiquinol oxidase activity of purified cytochrome bd-I from Escherichia coli. Biochimie 160:141–147
pubmed: 30790617 doi: 10.1016/j.biochi.2019.02.007
Gao L et al (2022) Nisin probiotic prevents inflammatory bone loss while promoting reparative proliferation and a healthy microbiome. NPJ Biofilms Microbiomes 8(1):45
pubmed: 35672331 pmcid: 9174264 doi: 10.1038/s41522-022-00307-x
George F et al (2018) Occurrence and dynamism of lactic acid bacteria in distinct ecological niches: a multifaceted functional health perspective. Front Microbiol 9:2899
pubmed: 30538693 pmcid: 6277688 doi: 10.3389/fmicb.2018.02899
Ghapanvari P et al (2022) The effect of nisin on the biofilm production, antimicrobial susceptibility and biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa. Front Microbiol 27(1):173
Giacometti F et al (2021) Antimicrobials and food-related stresses as selective factors for antibiotic resistance along the farm to fork continuum. Antibiotics 10(6):671
pubmed: 34199740 pmcid: 8230312 doi: 10.3390/antibiotics10060671
González-Gragera E et al (2024) Genomic characterization of piscicolin CM22 produced by Carnobacterium maltaromaticum CM22 strain isolated from salmon (Salmo salar). Probiot Antimicrob Proteins 16:1–13
Goulart DB et al (2022) Influence of single dose enrofloxacin injection on development of fluoroquinolone resistance in Campylobacter jejuni in calves. Antibiotics 11(10):1407
pubmed: 36290067 pmcid: 9598087 doi: 10.3390/antibiotics11101407
Gradisteanu Pircalabioru G et al (2021) Bacteriocins in the era of antibiotic resistance: rising to the challenge. Pharmaceutics 13(2):196
pubmed: 33540560 pmcid: 7912925 doi: 10.3390/pharmaceutics13020196
Gu Q (2023a) Bacteriocins. Springer, Singapore
doi: 10.1007/978-981-99-2661-9
Gu Q (2023b) Application of bacteriocins in the food industry. Springer, Singapore, pp 63–83
Gu Q et al (2024) Bacteriocins: curial guardians of gastrointestinal tract. Compr Rev Food Sci Food Saf 23(1):e13292
pubmed: 38284593 doi: 10.1111/1541-4337.13292
Guo X et al (2024) The antibacterial mechanism of the novel bacteriocin LpH25 and the synergistic preservation effect of this bacteriocin and Nisin in fresh milk. LWT 194:115766
doi: 10.1016/j.lwt.2024.115766
Haenni M et al (2022) Environmental contamination in a high-income country (France) by antibiotics, antibiotic-resistant bacteria, and antibiotic resistance genes: status and possible causes. Environ Int 159:107047
pubmed: 34923370 doi: 10.1016/j.envint.2021.107047
Hassan RR et al (2021) In vitro experiments of prokaryotic and eukaryotic antimicrobial peptide cytotoxicity in intestinal epithelial cells. Int J Hortic Agric Food Sci 5:06–14
Hernández-González JC et al (2021) Bacteriocins from lactic acid bacteria. A powerful alternative as antimicrobials, probiotics, and immunomodulators in veterinary medicine. Animals 11(4):979
pubmed: 33915717 pmcid: 8067144 doi: 10.3390/ani11040979
Hofkens N et al (2023) Microbisporicin (NAI-107) protects Galleria mellonella from infection with Neisseria gonorrhoeae. Microbiol Spectr 11(6):e02825-e12823
pubmed: 37823634 pmcid: 10715042 doi: 10.1128/spectrum.02825-23
Hofkens N et al (2024) Protective effect of microbisporicin (NAI-107) against vancomycin resistant Enterococcus faecium infection in a Galleria mellonella model. Sci Rep 14(1):4786
pubmed: 38413672 pmcid: 10899196 doi: 10.1038/s41598-024-55262-8
Homem NC et al (2023) Potential biomolecules of microbial origin against infectious diseases. Microbial systematics. CRC Press, Boca Raton, pp 14–42
doi: 10.1201/9781003307679-2
Huang F et al (2021) Bacteriocins: potential for human health. Oxid Med Cell Longev 2021:1–17
doi: 10.1155/2021/5518825
Huang F et al (2022) Nisin Z attenuates lipopolysaccharide-induced mastitis by inhibiting the ERK1/2 and p38 mitogen-activated protein kinase signaling pathways. J Dairy Sci 105(4):3530–3543
pubmed: 35181137 doi: 10.3168/jds.2021-21356
Ibrahim OO (2019) Classification of antimicrobial peptides bacteriocins, and the nature of some bacteriocins with potential applications in food safety and bio-pharmaceuticals. EC Microbiol 15(7):591–608
Ide N et al (2023) Different CprABC amino acid sequences affect nisin A susceptibility in Clostridioides difficile isolates. PLoS ONE 18(1):e0280676
pubmed: 36662820 pmcid: 9858009 doi: 10.1371/journal.pone.0280676
Impey RE et al (2020) Overcoming intrinsic and acquired resistance mechanisms associated with the cell wall of gram-negative bacteria. Antibiotics 9(9):623
pubmed: 32961699 pmcid: 7558195 doi: 10.3390/antibiotics9090623
Jena PK et al (2013) Bacteriocin PJ4 active against enteric pathogen produced by Lactobacillus helveticus PJ4 isolated from gut microflora of wistar rat (Rattus norvegicus): partial purification and characterization of bacteriocin. Appl Biochem Biotechnol 169:2088–2100
pubmed: 23371780 doi: 10.1007/s12010-012-0044-7
Jia Z et al (2019) Nisin reduces uterine inflammation in rats by modulating concentrations of pro-and anti-inflammatory cytokines. Am J Reprod Immunol 81(5):e13096
pubmed: 30681748 doi: 10.1111/aji.13096
Jiang H et al (2016) Heterologous expression and purification of plantaricin NC8, a two-peptide bacteriocin against Salmonella spp. from Lactobacillus plantarum ZJ316. Protein Expr Purif 127:28–34
pubmed: 27373940 doi: 10.1016/j.pep.2016.06.013
Johnson RM et al (2024) The hybrid antibiotic thiomarinol A overcomes intrinsic resistance in Escherichia coli using a privileged dithiolopyrrolone moiety. ACS Infect Dis 10(2):582–593
pubmed: 38226592 doi: 10.1021/acsinfecdis.3c00504
Kaneko N et al (2019) The role of interleukin-1 in general pathology. Inflamm Regen 39:1–16
doi: 10.1186/s41232-019-0101-5
Karimi M et al (2021) Effect of preconditioned mesenchymal stem cells with nisin prebiotic on the expression of wound healing factors such as TGF-β1, FGF-2, IL-1, IL-6, and IL-10. Regen Eng Transl Med 7:30–40
doi: 10.1007/s40883-021-00194-2
Khorshidian N et al (2021) Antibacterial activity of pediocin and pediocin-producing bacteria against Listeria monocytogenes in meat products. Front Microbiol 12:709959
pubmed: 34603234 pmcid: 8486284 doi: 10.3389/fmicb.2021.709959
Kingkaew E, Tanasupawat S (2024) Application of antimicrobial peptides from lactic acid bacteria in food preservation and human health. Antimicrobials in food science and technology. CRC Press, Boca Raton, pp 1–29
Kolawole OE et al (2024) Role of antimicrobial peptides in agriculture and industries. Antimicrobial peptides from lactic acid bacteria: diversity, biosynthesis and applications. Springer, Singapore, pp 307–338
doi: 10.1007/978-981-97-3413-9_12
Kranjec C et al (2021) Staphylococcal biofilms: challenges and novel therapeutic perspectives. Antibiotics 10(2):131
pubmed: 33573022 pmcid: 7911828 doi: 10.3390/antibiotics10020131
Krivorotova T et al (2016) Nisin-loaded pectin nanoparticles for food preservation. Food Hydrocolloids 54:49–56
doi: 10.1016/j.foodhyd.2015.09.015
Kuznetsova MV et al (2022) Bacteriocin-producing Escherichia coli isolated from the gastrointestinal tract of farm animals: prevalence, molecular characterization and potential for application. Microorganisms 10(8):1558
pubmed: 36013976 pmcid: 9413453 doi: 10.3390/microorganisms10081558
Ladjouzi R et al (2023) A review on enterocin DD14, the leaderless two-peptide bacteriocin with multiple biological functions and unusual transport pathway. Antibiotics 12(7):1188
pubmed: 37508284 pmcid: 10376788 doi: 10.3390/antibiotics12071188
Lencina FA et al (2024) Prevalence of colistin-resistant Escherichia coli in foods and food-producing animals through the food chain: a worldwide systematic review and meta-analysis. Heliyon 10:e26579
pubmed: 38434325 pmcid: 10904249 doi: 10.1016/j.heliyon.2024.e26579
Li G et al (2022) Vancomycin resistance in Enterococcus and Staphylococcus aureus. Microorganisms 11(1):24
pubmed: 36677316 pmcid: 9866002 doi: 10.3390/microorganisms11010024
Li W et al (2024a) Population and functional genomics of lactic acid bacteria, an important group of food microorganism: current knowledge, challenges, and perspectives. Food Front 5(1):3–23
doi: 10.1002/fft2.321
Li W et al (2024b) Effect of oral administration of microcin Y on growth performance, intestinal barrier function and gut microbiota of chicks challenged with Salmonella pullorum. Vet Res 55(1):66
pubmed: 38778424 pmcid: 11112776 doi: 10.1186/s13567-024-01321-x
Li Y et al (2024c) Isolation and identification of bacteriocin-producing lactic acid bacteria from Daqu and mining of bacteriocin gene. Biologia 71:9891–2905
Liang Y et al (2022) Antibacterial effects of bacteriocin PLNC8 against helicobacter pylori and its potential mechanism of action. Foods 11(9):1235
pubmed: 35563958 pmcid: 9104758 doi: 10.3390/foods11091235
Liu X et al (2023) Lactobacillus plantarum decreased ammonia emissions through modulating cecal microbiotain broilers challenged with ammonia. Animals 13(17):2739
pubmed: 37685002 pmcid: 10487022 doi: 10.3390/ani13172739
Lu J, Guo JJWR (2024) Prophage induction by non-antibiotic compounds promotes transformation of released antibiotic resistance genes from cell lysis. Water Res 263:122200
pubmed: 39111212 doi: 10.1016/j.watres.2024.122200
Lu S et al (2024) Bacillus-derived probiotics: metabolites and mechanisms involved in bacteria–host interactions. Crit Revi Food Sci Nutr 64(6):1701–1714
doi: 10.1080/10408398.2022.2118659
Małaczewska J et al (2019) In vitro immunomodulatory effect of nisin on porcine leucocytes. J Anim Physiol Anim Nutr 103(3):882–893
doi: 10.1111/jpn.13085
Marković KG et al (2022) Colicins and microcins produced by Enterobacteriaceae: characterization, mode of action, and putative applications. Int J Environ Res Public Health 19(18):11825
pubmed: 36142096 pmcid: 9517006 doi: 10.3390/ijerph191811825
Martín-Escolano R et al (2020) Assessing the effectiveness of AS-48 in experimental mice models of Chagas’ disease. J Antimicrob Chemother 75(6):1537–1545
pubmed: 32129856 doi: 10.1093/jac/dkaa030
Marzhoseyni Z et al (2022) Streptococcal bacterial components in cancer therapy. Cancer Gene Ther 29(2):141–155
pubmed: 33753868 doi: 10.1038/s41417-021-00308-6
McAnulty MJ et al (2024) The quorum sensing peptide BlpC regulates the transcription of genes outside its associated gene cluster and impacts the growth of Streptococcus thermophilus. Front Microbiol 14:1304136
pubmed: 38293552 pmcid: 10826417 doi: 10.3389/fmicb.2023.1304136
McInnes RS et al (2020) Horizontal transfer of antibiotic resistance genes in the human gut microbiome. Curr Opin Microbiol 53:35–43
pubmed: 32143027 doi: 10.1016/j.mib.2020.02.002
Meade E et al (2020) Bacteriocins, potent antimicrobial peptides and the fight against multi drug resistant species: resistance is futile? Antibiotics 9(1):32
pubmed: 31963311 pmcid: 7168330 doi: 10.3390/antibiotics9010032
Mithuna R et al (2024) Emergence of antibiotic resistance due to the excessive use of antibiotics in medicines and feed additives: a global scenario with emphasis on the Indian perspective. Emerg Contam 10:100389
doi: 10.1016/j.emcon.2024.100389
Molham F et al (2021) Anti-proliferative and anti-biofilm potentials of bacteriocins produced by non-pathogenic Enterococcus sp. Probiot Antimicrob Proteins 13(2):571–585
doi: 10.1007/s12602-020-09711-1
Montalbán-López M et al (2020) Synergy of the bacteriocin AS-48 and antibiotics against uropathogenic enterococci. Antibiotics 9(9):567
pubmed: 32887311 pmcid: 7558097 doi: 10.3390/antibiotics9090567
Mouritzen MV et al (2019) Immunomodulatory potential of Nisin A with application in wound healing. Wound Repair Regen 27(6):650–660
pubmed: 31287619 doi: 10.1111/wrr.12743
Mukhopadhyay S et al (2024) Evaluating the impact of climate change on antimicrobial resistance and rise in dysentery using next generation sequencing based approaches. Microbiology-2.0 update for a sustainable future. Springer, Singapore, pp 373–393
doi: 10.1007/978-981-99-9617-9_17
Murat DJL (2021) Food stabilizing potential of nisin Z produced by wild Lactococcus lactis subsp lactis from raw milk and some fermented products. LWT 150:112065
doi: 10.1016/j.lwt.2021.112065
Muteeb G et al (2023) Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals (Basel) 16(11):1615
pubmed: 38004480 doi: 10.3390/ph16111615
Negash AW, Tsehai BA (2020) Current applications of bacteriocin. In J Microbiol 2020(1):4374891
Nisa M et al (2023) Combating food spoilage and pathogenic microbes via bacteriocins: a natural and eco-friendly substitute to antibiotics. Food Control 149:109710
doi: 10.1016/j.foodcont.2023.109710
Oliveira FS et al (2024) Influence of different culture media on the antimicrobial activity of Pediococcus pentosaceus ST65ACC against Listeria monocytogenes. Braz J Microbiol 55:2539–2545
pubmed: 38789904
Ovchinnikov KV et al (2021) A strong synergy between the thiopeptide bacteriocin micrococcin P1 and rifampicin against MRSA in a murine skin infection model. Front Immunol 12:676534
pubmed: 34276663 pmcid: 8284338 doi: 10.3389/fimmu.2021.676534
Owusu FA et al (2023) Occurrence of carbapenemases, extended-spectrum beta-lactamases and AmpCs among beta-lactamase-producing Gram-negative bacteria from clinical sources in Accra, Ghana. Antibiotics 12(6):1016
pubmed: 37370334 pmcid: 10295373 doi: 10.3390/antibiotics12061016
Park SY et al (2023) Anti-obesity potential through regulation of carbohydrate uptake and gene expression in intestinal epithelial cells by the probiotic Lactiplantibacillus plantarum MGEL20154 from fermented food. J Microbiol Biotechnol 33(5):621
pubmed: 36864459 pmcid: 10236178 doi: 10.4014/jmb.2212.12005
Parmanik A et al (2022) Current treatment strategies against multidrug-resistant bacteria: a review. Curr Microbiol 79(12):388
pubmed: 36329256 pmcid: 9633024 doi: 10.1007/s00284-022-03061-7
Pérez-Ramos A et al (2021) Current knowledge of the mode of action and immunity mechanisms of LAB-bacteriocins. Microorganisms 9(10):2107
pubmed: 34683428 pmcid: 8538875 doi: 10.3390/microorganisms9102107
Poorni S et al (2022) Effect of probiotic Streptococcus salivarius K12 and M18 lozenges on the cariogram parameters of patients with high caries risk: a randomised control trial. Cureus 14(3):e23282
pubmed: 35449617 pmcid: 9012604
Popović N et al (2024) Insight into the probiogenomic potential of Enterococcus faecium BGPAS1–3 and application of a potent thermostable bacteriocin. Footds 13(16):2637
Qadri H et al (2021) Novel strategies to combat the emerging drug resistance in human pathogenic microbes. Curr Drug Targets 22(12):1424–1436
pubmed: 33371847
Qadri H et al (2022) Natural products and their semi-synthetic derivatives against antimicrobial-resistant human pathogenic bacteria and fungi. Saudi J Biol Sci 29(9):103376
pubmed: 35874656 pmcid: 9290337 doi: 10.1016/j.sjbs.2022.103376
Robles-Jimenez LE et al (2021) Worldwide traceability of antibiotic residues from livestock in wastewater and soil: a systematic review. Animals 12(1):60
pubmed: 35011166 pmcid: 8749557 doi: 10.3390/ani12010060
Sahithi SA et al (2023) Lantibiotics production—optimization and scale-up research: cutting edge and challenges. Lantibiotics as alternative therapeutics. Elsevier, Amsterdam, pp 427–459
doi: 10.1016/B978-0-323-99141-4.00020-5
Salman MK et al (2023) Anti-quorum sensing activity of probiotics: the mechanism and role in food and gut health. Microorganisms 11(3):793
pubmed: 36985366 pmcid: 10056907 doi: 10.3390/microorganisms11030793
Salvador PBU et al (2021) Immunomodulatory potential of four candidate probiotic Lactobacillus strains from plant and animal origin using comparative genomic analysis. Access Microbiol 3(12):000299
pubmed: 35024559 pmcid: 8749136 doi: 10.1099/acmi.0.000299
Santos R et al (2019) Diabetic foot infections: application of a nisin-biogel to complement the activity of conventional antibiotics and antiseptics against Staphylococcus aureus biofilms. PLoS ONE 14(7):e0220000
pubmed: 31339915 pmcid: 6655664 doi: 10.1371/journal.pone.0220000
Saravanan P et al (2023) Anti-inflammatory and wound healing properties of lactic acid bacteria and its peptides. Folia Microbiol (Praha) 68(3):337–353
pubmed: 36780113 doi: 10.1007/s12223-022-01030-y
Schneider CL (2021) Bacteriophage-mediated horizontal gene transfer: transduction. Bacteriophages: biology, technology, therapy. Springer, Cham, pp 151–192
doi: 10.1007/978-3-319-41986-2_4
Sedgley CM et al (2009) Plasmid pAMS1-encoded, bacteriocin-related “Siblicide” in Enterococcus faecalis. J Bacteriol 191(9):3183–3188
pubmed: 19270087 pmcid: 2681816 doi: 10.1128/JB.00147-09
Sharma P et al (2022) Enhancing antibacterial properties of bacteriocins using combination therapy. J Biol Appl Biotechnol 11(1):232–243
Shevade A, Naik S (2023) Mitigation of antimicrobial resistance (AMR) in G20. Indian Public Policy Rev 4(4 (Jul-Aug)):1–29
doi: 10.55763/ippr.2023.04.04.001
Shin JM et al (2015) Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells. Front Microbiol 6:617
pubmed: 26150809 pmcid: 4471743 doi: 10.3389/fmicb.2015.00617
Silva A et al (2023) Antimicrobial resistance and clonal lineages of Escherichia coli from food-producing animals. Antibiotics 12(6):1061
pubmed: 37370379 pmcid: 10295564 doi: 10.3390/antibiotics12061061
Simons A et al (2020) Bacteriocins, antimicrobial peptides from bacterial origin: overview of their biology and their impact against multidrug-resistant bacteria. Microorganisms 8(5):639
pubmed: 32349409 pmcid: 7285073 doi: 10.3390/microorganisms8050639
Smaoui S et al (2024) Beyond conventional meat preservation: saddling the control of bacteriocin and lactic acid bacteria for clean label and functional meat products. Appl Biochem Biotechnol 196(6):3604–3635
pubmed: 37615854 doi: 10.1007/s12010-023-04680-x
Smits SH et al (2020) Self-immunity to antibacterial peptides by ABC transporters. FEBS Lett 594(23):3920–3942
pubmed: 33040342 doi: 10.1002/1873-3468.13953
Solis-Balandra MA, Sanchez-Salas JL (2024) Classification and multi-functional use of bacteriocins in health, biotechnology and food industry. Antibiotics 13:666
pubmed: 39061348 pmcid: 11273373 doi: 10.3390/antibiotics13070666
Soltani S et al (2021) Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations. FEMS Microbiol Rev 45(1):fuaa039
pubmed: 32876664 doi: 10.1093/femsre/fuaa039
Soltani S et al (2022) Gastrointestinal stability and cytotoxicity of bacteriocins from gram-positive and gram-negative bacteria: a comparative in vitro study. Front Microbiol 12:780355
pubmed: 35145490 pmcid: 8824275 doi: 10.3389/fmicb.2021.780355
Sousa MC (2024) New insights into the pathogenicity of Listeria monocytogenes clonal complexes. Doctoral dissertation
Tagg JR et al (2023) Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics. Fron Microbiol 14:1161155
doi: 10.3389/fmicb.2023.1161155
Tavares TD et al (2023) Combinatory effect of nisin antimicrobial peptide with bioactive molecules: a review. J Drug Deliv Sci Technol 91:105246
doi: 10.1016/j.jddst.2023.105246
Teiar R et al (2022) Anti-adhesion and anti-inflammatory potential of the leaderless class IIb bacteriocin enterocin DD14. Probiot Antimicrob Proteins 14(4):613–619
doi: 10.1007/s12602-022-09954-0
Tejesvi M et al (2016) MB1533 is a defensin-like antimicrobial peptide from the intracellular meristem endophyte of Scots pine Methylobacterium extorquens DSM13060. J Microb Biochem Technol 8(1):1–5
Telhig S et al (2022) Evaluating the potential and synergetic effects of microcins against multidrug-resistant Enterobacteriaceae. Microbio Spectr 10(3):e02752-e2721
Thakur A et al (2022) In pursuit of next-generation therapeutics: antimicrobial peptides against superbugs, their sources, mechanism of action, nanotechnology-based delivery, and clinical applications. Int J Biol Macromol 218:135–156
pubmed: 35868409 doi: 10.1016/j.ijbiomac.2022.07.103
Thoda C, Touraki MJM (2023) Probiotic-derived bioactive compounds in colorectal cancer treatment. Microorganisms 11(8):1898
pubmed: 37630458 pmcid: 10456921 doi: 10.3390/microorganisms11081898
Thuy TTD et al (2024) Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods. BMC Microbiol 24(1):85
pubmed: 38468236 pmcid: 10926564 doi: 10.1186/s12866-024-03245-0
Tönz A et al (2024) Growth control of Listeria monocytogenes in raw sausage via bacteriocin-producing Leuconostoc carnosum DH25. Foods 13(2):298
pubmed: 38254599 pmcid: 10815048 doi: 10.3390/foods13020298
Tripartite, WHO (2021) UNEP support OHHLEP’s definition of "One Health". Joint Tripartite (FAO, OIE, WHO) and UNEP Statement. WHO
Uddin TM et al (2021) Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and future prospects. J Infect Public Health 14(12):1750–1766
pubmed: 34756812 doi: 10.1016/j.jiph.2021.10.020
Van Gijtenbeek LA et al (2021) Gene-trait matching and prevalence of Nisin tolerance systems in Lactococus lactis. Front Bioeng Biotechnol 9:622835
pubmed: 33748081 pmcid: 7965974 doi: 10.3389/fbioe.2021.622835
Verma MK et al (2021) Trends in antimicrobial therapy: current approaches and future prospects. biomolecular engineering solutions for renewable specialty chemicals: microorganisms, products, and processes. Wiley, Hoboken, pp 111–140
doi: 10.1002/9781119771951.ch4
Vidhyasagar V, Jeevaratnam K (2013) Evaluation of Pediococcus pentosaceus strains isolated from idly batter for probiotic properties in vitro. J Funct Foods 5(1):235–243
doi: 10.1016/j.jff.2012.10.012
Wang G et al (2020) Effect of antimicrobial peptide microcin J25 on growth performance, immune regulation, and intestinal microbiota in broiler chickens challenged with Escherichia coli and Salmonella. Animals 10(2):345
pubmed: 32098236 pmcid: 7070248 doi: 10.3390/ani10020345
Wang Y et al (2024) The progress of the biotechnological production of class IIa bacteriocins in various cell factories and its future challenges. Int J Mol Sci 25(11):5791
pubmed: 38891977 pmcid: 11172294 doi: 10.3390/ijms25115791
Wayah SB, Philip K (2018) Pentocin MQ1: a novel, broad-spectrum, pore-forming bacteriocin from Lactobacillus pentosus CS2 with quorum sensing regulatory mechanism and biopreservative potential. Front Microbiol 9:564
pubmed: 29636737 pmcid: 5880951 doi: 10.3389/fmicb.2018.00564
Williams ET (2021) Chemo-enzymatic strategies towards the total synthesis of lexapeptide. University of Auckland, Auckland
World Health O (2019) WHO benchmarks for International Health Regulations (IHR) capacities
Xiang Y-Z et al (2022) Antibacterial effect of bacteriocin XJS01 and its application as antibiofilm agents to treat multidrug-resistant Staphylococcus aureus infection. Int J Biol Macromol 196:13–22
pubmed: 34838856 doi: 10.1016/j.ijbiomac.2021.11.136
Yaacob SN et al (2022) Lactic acid bacteria and their bacteriocins: new potential weapons in the fight against methicillin-resistant Staphylococcus aureus. Future Microbiol 17(9):683–699
pubmed: 35414206 doi: 10.2217/fmb-2021-0256
Ye C et al (2024) Nisin, a probiotic bacteriocin, modulates the inflammatory and microbiome changes in female reproductive organs mediated by polymicrobial periodontal infection. Microorganisms 12(8):1647
pubmed: 39203489 pmcid: 11357294 doi: 10.3390/microorganisms12081647
Yu H et al (2020) Therapeutic administration of the recombinant antimicrobial peptide microcin J25 effectively enhances host defenses against gut inflammation and epithelial barrier injury induced by enterotoxigenic Escherichia coli infection. FASEB J 34(1):1018–1037
pubmed: 31914603 doi: 10.1096/fj.201901717R
Yu H et al (2022) Biosynthetic microcin J25 exerts strong antibacterial, anti-inflammatory activities, low cytotoxicity without increasing drug-resistance to bacteria target. Front Immunol 13:811378
pubmed: 35250983 pmcid: 8894198 doi: 10.3389/fimmu.2022.811378
Zhang H et al (2022) The impact of Mycobacterium tuberculosis complex in the environment on one health approach. Front Public Health 10:994745
pubmed: 36159313 pmcid: 9489838 doi: 10.3389/fpubh.2022.994745
Ziegler CA et al (2021) The leucine-responsive regulatory proteins/feast-famine regulatory proteins: an ancient and complex class of transcriptional regulators in bacteria and archaea. Crit Rev Biochem Mol Biol 56(4):373–400
pubmed: 34151666 pmcid: 9239533 doi: 10.1080/10409238.2021.1925215
Zimina M et al (2020) Overview of global trends in classification, methods of preparation and application of bacteriocins. Antibiotics 9(9):553
pubmed: 32872235 pmcid: 7559574 doi: 10.3390/antibiotics9090553

Auteurs

Safura Nisar (S)

Department of Bioresources, School of Biological Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, India.

Abdul Haseeb Shah (AH)

Department of Bioresources, School of Biological Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, India. abdulhaseeb@kashmiruniversity.ac.in.

Ruqeya Nazir (R)

Centre of Research for Development (CORD), School of Biological Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, India. ruqeya@uok.edu.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH